Tenon Medical, Inc.
TNON
$1.46
$0.4443.14%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.97% | -4.70% | -6.04% | 21.27% | 66.05% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.97% | -4.70% | -6.04% | 21.27% | 66.05% |
| Cost of Revenue | 61.85% | 67.47% | 14.67% | -21.49% | -48.13% |
| Gross Profit | -31.28% | -36.85% | -21.87% | 142.27% | 1,100.00% |
| SG&A Expenses | 0.06% | -1.73% | -6.30% | 0.53% | -17.43% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.21% | -0.15% | -5.09% | -5.77% | -20.57% |
| Operating Income | -4.88% | -1.02% | 4.83% | 10.41% | 28.24% |
| Income Before Tax | -1.12% | 1.50% | 4.44% | 10.71% | 25.96% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.12% | 1.50% | 4.44% | 10.71% | 25.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.12% | 1.50% | 4.44% | 10.71% | 25.96% |
| EBIT | -4.88% | -1.02% | 4.83% | 10.41% | 28.24% |
| EBITDA | -6.72% | -0.26% | 6.57% | 11.76% | 29.93% |
| EPS Basic | 89.96% | 90.08% | 68.95% | 68.92% | 70.86% |
| Normalized Basic EPS | 89.96% | 90.08% | 68.95% | 68.92% | 70.86% |
| EPS Diluted | 89.96% | 90.08% | 68.95% | 68.92% | 70.86% |
| Normalized Diluted EPS | 89.96% | 90.08% | 68.95% | 68.92% | 70.86% |
| Average Basic Shares Outstanding | 907.56% | 893.38% | 207.72% | 187.31% | 154.09% |
| Average Diluted Shares Outstanding | 907.56% | 893.38% | 207.72% | 187.31% | 154.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |